Sansure Biotech Inc (688289) — Capital Reinvestment Ratio
Sansure Biotech Inc (688289) has a Capital Reinvestment Ratio of 1.06x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥59.72 Million) in capital expenditures (CN¥63.08 Million). Check 688289 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sansure Biotech Inc Capital Reinvestment Ratio (2018–2025)
This chart tracks Sansure Biotech Inc's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see 688289 cash flow metrics.
Annual Capital Reinvestment Ratio for Sansure Biotech Inc (2018–2025)
Year-by-year Capital Reinvestment Ratio for Sansure Biotech Inc from 2018 to 2025. See Sansure Biotech Inc (688289) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.01x | CN¥183.96 Million | CN¥369.77 Million | ▲ +31.0% |
| 2024 | 1.53x | CN¥274.45 Million | CN¥421.10 Million | ▼ -55.8% |
| 2023 | 3.47x | CN¥112.82 Million | CN¥391.35 Million | ▲ +1488.4% |
| 2022 | 0.22x | CN¥2.56 Billion | CN¥558.83 Million | ▲ +9.9% |
| 2021 | 0.20x | CN¥1.88 Billion | CN¥372.86 Million | ▲ +383.0% |
| 2020 | 0.04x | CN¥2.64 Billion | CN¥108.67 Million | ▼ -97.3% |
| 2019 | 1.52x | CN¥22.41 Million | CN¥34.14 Million | ▼ -53.4% |
| 2018 | 3.27x | CN¥10.07 Million | CN¥32.90 Million | — |